FACSX
Price
$47.91
Change
+$0.46 (+0.97%)
Updated
May 8 closing price
Net Assets
376.88M
MVCAX
Price
$29.45
Change
+$0.35 (+1.20%)
Updated
May 8 closing price
Net Assets
16.28B
Ad is loading...

FACSX vs MVCAX

Header iconFACSX vs MVCAX Comparison
Open Charts FACSX vs MVCAXBanner chart's image
Nuveen Mid Cap Value 1 C
Price$47.91
Change+$0.46 (+0.97%)
VolumeN/A
Net Assets376.88M
MFS Mid Cap Value A
Price$29.45
Change+$0.35 (+1.20%)
VolumeN/A
Net Assets16.28B
FACSX vs MVCAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FACSX vs. MVCAX commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FACSX is a Buy and MVCAX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
MVCAX has more cash in the bank: 16.3B vs. FACSX (377M). MVCAX pays higher dividends than FACSX: MVCAX (0.93) vs FACSX (0.20). FACSX was incepted earlier than MVCAX: FACSX (26 years) vs MVCAX (24 years). FACSX (1.97) is less costly to investors than MVCAX (1.00). MVCAX is a more actively managed with annual turnover of: 27.00 vs. FACSX (20.00). MVCAX has a lower initial minimum investment than FACSX: MVCAX (1000) vs FACSX (2500). FACSX annual gain was more profitable for investors over the last year : -5.88 vs. MVCAX (-8.27). FACSX (58.67) and MVCAX (56.76) have equivalent 5 years return.
FACSXMVCAXFACSX / MVCAX
Total Expense Ratio1.880.99190%
Annual Report Gross Expense Ratio1.971.00197%
Fund Existence26 years24 years-
Gain YTD-5.289-5.150103%
Front LoadN/A6%-
Min. Initial Investment25001000250%
Min. Initial Investment IRAN/AN/A-
Net Assets377M16.3B2%
Annual Yield % from dividends0.200.9321%
Returns for 1 year-5.88-8.2771%
Returns for 3 years0.934.6120%
Returns for 5 years58.6756.76103%
Returns for 10 years38.1549.3577%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SPFCX17.21N/A
N/A
PGIM Jennison Focused Growth C
CNREX22.67N/A
N/A
Commonwealth Real Estate Securities
FADTX106.29N/A
N/A
Fidelity Advisor Technology A
DLACX14.02N/A
N/A
BNY Mellon Large Cap Equity Y
BSGRX12.15N/A
N/A
BlackRock Advantage Small Cap Gr R